Literature DB >> 10915592

Cytokine-mediated control of viral infections.

L G Guidotti1, F V Chisari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10915592     DOI： 10.1006/viro.2000.0442

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  40 in total

1.  Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Authors:  Gerlinde R Van de Walle; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

3.  Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ.

Authors:  Manohar B Mutnal; Shuxian Hu; Morgan R Little; James R Lokensgard
Journal:  J Neurovirol       Date:  2011-07-29       Impact factor: 2.643

4.  Up-regulation of IL-12 expression in patients with chronic hepatitis B is mediated by the PI3K/Akt pathway.

Authors:  Hong-wei Wang; Hai-li Gao; Xiao-xia Wei; Xin-hong Wang
Journal:  Mol Cell Biochem       Date:  2015-06-11       Impact factor: 3.396

5.  CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection.

Authors:  Robert Thimme; Stefan Wieland; Carola Steiger; John Ghrayeb; Keith A Reimann; Robert H Purcell; Francis V Chisari
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Common antiviral cytotoxic t-lymphocyte epitope for diverse arenaviruses.

Authors:  M B Oldstone; H Lewicki; D Homann; C Nguyen; S Julien; J E Gairin
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.

Authors:  Robyn Puro; Robert J Schneider
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

Review 8.  [Hepatitis as a travel disease].

Authors:  J Hadem; H Wedemeyer; M P Manns
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

9.  Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals.

Authors:  Christina M Martin; Jeffrey A Welge; Norah J Shire; Mohamed T Shata; Kenneth E Sherman; Jason T Blackard
Journal:  Cytokine       Date:  2009-07-21       Impact factor: 3.861

10.  Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers.

Authors:  Se Jin Im; Se-Hwan Yang; Seung Kew Yoon; Young Chul Sung
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.